President Trump is promising more payments to voters just ahead of the Nov. 3 midterm elections — this time for seniors' Medicare Part B premiums ...

Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.

Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...

Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...

News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...

Merck discontinued Recarbio, an important antibiotic in the U.S., despite concerns over resistance to superbugs.

Chinese-designed drugs now account for roughly half the global pipeline. STAT's Jason Mast traveled to Shanghai to get an up-close look at the competition that's making American's nervous.

The gene-editing company Beam Therapeutics is alleging that one of its scientists stole intellectual property and used it to ...

DHS has appealed a court ruling blocking it from restricting how long international students and postdoctoral researchers can ...

The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.

The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...